MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

02 Feb 2022 Evaluate
The revenue zoomed 8.80% to Rs. 129.20 millions for the quarter ended December 2021 as compared to Rs. 118.75 millions during the corresponding quarter last year.Net profit of the cmpany stood at Rs. 13.71 millions for the quarter ended December 2021 a decline of -39.12% from Rs. 22.52 millions  in the same quarter last year.The company reported a good operating profit of 57.54 millions compared to 47.84 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 129.20 118.75 8.80 360.85 356.94 1.10 517.75 553.52 -6.46
Other Income 0.00 0.00 0.00 2.44 0.00 0.00 0.79 0.53 49.06
PBIDT 57.54 47.84 20.28 144.52 136.57 5.82 177.43 125.24 41.67
Interest 12.04 5.43 121.73 31.28 22.77 37.37 35.29 30.98 13.91
PBDT 45.50 42.41 7.29 113.24 113.80 -0.49 142.14 94.26 50.80
Depreciation 17.10 13.15 30.04 52.36 38.38 36.43 55.91 51.72 8.10
PBT 28.40 29.26 -2.94 60.88 75.42 -19.28 86.23 42.54 102.70
TAX 14.69 6.74 117.95 32.09 21.58 48.70 29.37 -1.89 -1653.97
Deferred Tax 10.31 -3.64 -383.24 19.63 1.97 896.45 15.79 -13.11 -220.44
PAT 13.71 22.52 -39.12 28.79 53.84 -46.53 56.86 44.43 27.98
Equity 142.05 128.88 10.22 142.05 128.88 10.22 134.19 128.88 4.12
PBIDTM(%) 44.54 40.29 10.55 40.05 38.26 4.67 34.27 22.63 51.46
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..